Event Capital Strategies, based in New York City, focuses on thematic investing in large, consolidated markets ripe for disruption. The firm leverages its unique perspective, innovative ideas, global network, and extensive experience in acquiring and operating businesses to identify investment opportunities. Their typical investment stage appears to be Series B.
The firm's portfolio includes Piccolo Medical, a medical technology company that has raised $5.5 million. Event Capital Strategies aims to support innovative companies that can transform established industries through technological advancements and novel business models. Their investment philosophy emphasizes identifying and capitalizing on transformative trends in various sectors.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.